rs974276

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000125.4(ESR1):​c.1369+161A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 152,148 control chromosomes in the GnomAD database, including 5,303 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.22 ( 5303 hom., cov: 33)

Consequence

ESR1
NM_000125.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0510

Publications

11 publications found
Variant links:
Genes affected
ESR1 (HGNC:3467): (estrogen receptor 1) This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020]
ESR1 Gene-Disease associations (from GenCC):
  • estrogen resistance syndrome
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 6-152061285-A-G is Benign according to our data. Variant chr6-152061285-A-G is described in ClinVar as Benign. ClinVar VariationId is 1241299.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.431 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ESR1NM_000125.4 linkc.1369+161A>G intron_variant Intron 6 of 7 ENST00000206249.8 NP_000116.2 P03372-1G4XH65

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ESR1ENST00000206249.8 linkc.1369+161A>G intron_variant Intron 6 of 7 1 NM_000125.4 ENSP00000206249.3 P03372-1

Frequencies

GnomAD3 genomes
AF:
0.219
AC:
33292
AN:
152030
Hom.:
5293
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.436
Gnomad AMI
AF:
0.130
Gnomad AMR
AF:
0.107
Gnomad ASJ
AF:
0.110
Gnomad EAS
AF:
0.369
Gnomad SAS
AF:
0.233
Gnomad FIN
AF:
0.200
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.111
Gnomad OTH
AF:
0.204
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.219
AC:
33339
AN:
152148
Hom.:
5303
Cov.:
33
AF XY:
0.220
AC XY:
16374
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.436
AC:
18078
AN:
41474
American (AMR)
AF:
0.106
AC:
1628
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.110
AC:
383
AN:
3470
East Asian (EAS)
AF:
0.369
AC:
1910
AN:
5174
South Asian (SAS)
AF:
0.230
AC:
1111
AN:
4828
European-Finnish (FIN)
AF:
0.200
AC:
2116
AN:
10582
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.111
AC:
7525
AN:
68006
Other (OTH)
AF:
0.206
AC:
435
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1187
2374
3562
4749
5936
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.147
Hom.:
3199
Bravo
AF:
0.220
Asia WGS
AF:
0.295
AC:
1024
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.4
DANN
Benign
0.35
PhyloP100
-0.051
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs974276; hg19: chr6-152382420; COSMIC: COSV52798424; COSMIC: COSV52798424; API